VERAXA Biotech Raises $27.5M
VERAXA Biotech secures financing and plans to go public via SPAC, aiming to expand its biotech operations. The deal values the company and provides growth capital.
VERAXA Biotech secures financing and plans to go public via SPAC, aiming to expand its biotech operations.
The deal values the company and provides growth capital.